PCM
TPTX

Prelude Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Prelude Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-69,038
Closed -$5.2M – 1998
2022
Q2 		$5.2M Buy
+69,038
New +$5.2M 0.15% 77
2019
Q4 		– Sell
-11
Closed – – 1877
2019
Q3 		$0 Buy
+11
New – ﹤0.01% 1728